[HTML][HTML] IgG4 antibodies induced by repeated vaccination may generate immune tolerance to the SARS-CoV-2 spike protein

VN Uversky, EM Redwan, W Makis, A Rubio-Casillas - Vaccines, 2023 - mdpi.com
Less than a year after the global emergence of the coronavirus SARS-CoV-2, a novel
vaccine platform based on mRNA technology was introduced to the market. Globally, around …

Pertussis re-emergence in the post-vaccination era

E Chiappini, A Stival, L Galli, M De Martino - BMC infectious diseases, 2013 - Springer
Background Resurgence of pertussis in the post-vaccination era has been reported in
Western countries. A shift of cases from school-age children to adolescents, adults and …

Key steps in vaccine development

PL Stern - Annals of Allergy, Asthma & Immunology, 2020 - Elsevier
Objective The goal of a vaccine is to prime the immune response so the immune memory
can facilitate a rapid response to adequately control the pathogen on natural infection and …

Immune persistence after pertussis vaccination

Z Chen, Q He - Human vaccines & immunotherapeutics, 2017 - Taylor & Francis
Pertussis is one of the most prevalent vaccine-preventable diseases worldwide. The true
infection rate is significantly higher than the reported incidence rate. An increased …

Safety of Tdap vaccine in pregnant women: an observational study

H Petousis-Harris, T Walls, D Watson, J Paynter… - BMJ open, 2016 - bmjopen.bmj.com
Objectives Actively recruit and intensively follow pregnant women receiving a dose of
acellular pertussis vaccine for 4 weeks after vaccination. Design and settings A prospective …

[HTML][HTML] Tetanus–diphtheria–acellular pertussis vaccination for adults: an update

HJ Lee, JH Choi - Clinical and experimental vaccine research, 2017 - ncbi.nlm.nih.gov
Although tetanus and diphtheria have become rare in developed countries, pertussis is still
endemic in some developed countries. These are vaccine-preventable diseases and …

Factors influencing women's decisions about having the pertussis-containing vaccine during pregnancy

L Hill, B Burrell, T Walls - Journal of primary health care, 2018 - CSIRO Publishing
ABSTRACT INTRODUCTION New Zealand experienced a major epidemic of pertussis from
September 2011 to January 2014. In response to this epidemic, a pertussis-containing …

Immunopharmacotherapeutic advancements in addressing methamphetamine abuse

JC Lee, KD Janda - RSC Chemical Biology, 2021 - pubs.rsc.org
Methamphetamine (METH) is an illicit psychostimulant that is known to account for
substance abuse disorders globally, second only to opioids, yet has no approved …

Combined reduced-antigen content tetanus, diphtheria, and acellular pertussis (tdap) vaccine-related erythema nodosum: case report and review of vaccine …

PR Cohen - Dermatology and Therapy, 2013 - Springer
Background Vaccination programs reduce the morbidity and mortality of diphtheria,
pertussis, and tetanus. Erythema nodosum is a reactive erythema that can be associated …

Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children …

HJ Sharma, S Parekh, P Pujari, S Shewale… - Expert Review of …, 2023 - Taylor & Francis
Background This study assessed safety and immunogenicity of Serum Institute of India Pvt
Ltd (SIIPL)'s tetanus toxoid (TT), diphtheria toxoid (DT), and acellular pertussis booster …